(19)
(11) EP 1 434 570 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
26.10.2005 Bulletin 2005/43

(45) Mention of the grant of the patent:
31.08.2005 Bulletin 2005/35

(21) Application number: 02775048.8

(22) Date of filing: 30.09.2002
(51) International Patent Classification (IPC)7: A61K 9/22, A61K 9/52, A61K 31/517, A61P 13/08
(86) International application number:
PCT/IB2002/004040
(87) International publication number:
WO 2003/032956 (24.04.2003 Gazette 2003/17)

(54)

PHARMACEUTICAL FORMULATIONS FOR THE CONTROLLED RELEASE OF 4-AMINO-6,7-DIMETHOXY-2-(5-METHANESULFONAMIDO-1,2,3,4-TETRAHYDROISOQUINOL-2-YL)-5-(2-PYRIDYL)QUINAZOLINE

PHARMAZEUTISCHE FORMULIERUNGEN ZUR GESTEUERTEN FREISETZUNG VON 4-AMINO-6,7-DIMETHOXY-2-(5-METHANESULFONAMIDO-1,2,3,4-TETRAHYDROISOCHINOL-2-YL)-5-(2-PYRIDYL)CHINAZOLIN

FORMULATIONS PHARMACEUTIQUES DESTINEES A LA LIBERATION CONTROLEE DE 4-AMINO-6,7-DIMETHOXY-2-(5-METHANESULFONAMIDO-1,2,3,4-TETRAHYDROISOQUINOL-2-YL)-5-(2-PYRIDYL) QUINAZOLINE

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 11.10.2001 GB 0124455

(43) Date of publication of application:
07.07.2004 Bulletin 2004/28

(73) Proprietors:
  • Pfizer Limited
    Sandwich, Kent CT13 9NJ (GB)
    Designated Contracting States:
    GB 
  • PFIZER INC.
    New York, N.Y. 10017 (US)
    Designated Contracting States:
    AT BE BG CH CY CZ DE DK EE ES FI FR GR IE IT LU MC NL PT SE SK TR 

(72) Inventors:
  • DAVIS, John, D., Pfizer Global Research and Dev.
    Sandwich, Kent CT13 9NJ (GB)
  • HUMPHREY, Michael, J., Pfizer Global Rch. and Dev.
    Sandwich, Kent CT13 9NJ (GB)
  • MACRAE, Ross, J., Pfizer Global Research and Dev.
    Sandwich, Kent CT13 9NJ (GB)
  • SMITH, Janet, S., Pfizer Global Research and Dev.
    Sandwich, Kent CT13 9NJ (GB)

(74) Representative: Bridle, Andrew Barry 
Pfizer Limited UK Patent Department Ramsgate Road
Sandwich, Kent CT13 9NJ
Sandwich, Kent CT13 9NJ (GB)


(56) References cited: : 
EP-A- 0 466 986
WO-A-01/64672
FR-A- 2 752 737
 EP-A- 1 123 705
WO-A-98/30560
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).